Notably, BRAFWT patients with low TLS (TLSLow) and BRAFMT patients with high TLS (TLSHigh) demonstrated comparable OS, suggesting that robust TLS formation may overcome the adverse prognostic impact of BRAF mutations in CRC. Here, BRAF is linked to colorectal carcinoma.